China has come to Africa. Can U.S. policy makers find ways to mesh, not clash, with Beijing’s interests? By Christopher C. Starling.
Do needle-exchange programs ward off disease—or consign addicts to death on the installment plan?
The factors underlying disparities in treatment
Regulation and risk aversion hinder advancement
Medical science won't support smoking
Medicare needs to cut costs, escape political interference, and stay in business. Here’s how it can do all three. By Daniel P. Kessler.
Can public policy support the institution of friendship?
Trouble at the core of the medical economy